drugset / Trial / NCT04807517
Buspirone Treatment of Anxiety in Williams Syndrome
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to do a preliminary assessment of whether buspirone is effective, safe, and tolerable in the treatment of anxiety in children, adolescents, and adults with Williams syndrome.
Timeline
- Start
- 2021-08-01
- Primary completion
- 2023-09-11
- Completion
- 2023-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buspirone | Small molecule | 2.5 mg | Oral |